Strategic Partnerships STEQ America already aligns with multiple leading European manufacturers and provides lifecycle support from installation to service. This presents an opportunity to upsell bundled equipment packages, cross-sell additional aseptic and packaging solutions, and expand distributor-like partnerships to reach more U.S. biopharma manufacturers seeking integrated systems.

Aseptic Focus With a specialization in aseptic fill-finish, sterilization, and barrier isolation systems, target mid to large biotech firms expanding sterile manufacturing capacity or upgrading to compliant cGMP infrastructure. Propose turnkey solutions that reduce contamination risk and streamline validation to accelerate time-to-market.

Event-Driven Access Active participation in ISPE events, PDA Week, and trade shows indicates strong opportunity to generate demos and on-site assessments. Leverage conference exposure to schedule executive briefings, present ROI analyses, and capture inbound inquiries from companies planning CapEx investments in sterile manufacturing.

Mid-Mized Footprint Current revenue range ($10M–$25M) and 11–50 employees suggest growth potential with targeted account-based selling to mid-market pharma manufacturers seeking scalable, compliant equipment. Propose modular, scalable systems with flexible service contracts to align with potential buyer budgets and rapid deployment timelines.

Global-Local Advantage As a US-based company representing European manufacturers, emphasize local support and lifecycle service as a differentiator. Highlight opportunities to offer enhanced after-sales packages, extended warranties, and rapid on-site service for critical equipment to reduce downtime for U.S. customers facing regulatory scrutiny.